Published in J Neurochem on June 01, 1980
Requirement for nonoligodendrocyte cell signals for enhanced myelinogenic gene expression in long-term cultures of purified rat oligodendrocytes. Proc Natl Acad Sci U S A (1981) 0.86
Selective tropism of a neurotropic coronavirus for ependymal cells, neurons, and meningeal cells. J Virol (1986) 0.83
Myelination in rat brain: method of myelin isolation. J Neurochem (1973) 4.01
Prostaglandins modulate macrophage Ia expression. Nature (1982) 3.83
Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat Med (1999) 3.66
Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol (1988) 3.63
Corticosteroids inhibit murine macrophage Ia expression and interleukin 1 production. J Immunol (1982) 3.61
Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med (2000) 3.20
T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science (1994) 3.00
Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome. Science (1973) 2.91
Multiple sclerosis: distribution of T cell subsets within active chronic lesions. Science (1983) 2.91
Observations on viral demyelinating encephalomyelitis. Canine distemper. Lab Invest (1972) 2.88
Adrenoleukodystrophy. A clinical and pathological study of 17 cases. Arch Neurol (1975) 2.86
Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1. J Immunol (1991) 2.80
Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med (1994) 2.70
The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol (1995) 2.57
Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J Exp Med (1997) 2.51
Late complications of immune deviation therapy in a nonhuman primate. Science (1996) 2.30
Isolation of an HTLV-1-like retrovirus from patients with tropical spastic paraparesis. Nature (1988) 2.27
Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J Immunol (2001) 2.27
The behavioural pattern of social and religious water-contact activities in the Egypt-49 bilharziasis project area. Bull World Health Organ (1966) 2.19
Electron microscopic observations on the cerebellar cortex in kuru. J Neurol Sci (1969) 2.14
Homing to central nervous system vasculature by antigen-specific lymphocytes. I. Localization of 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis. Lab Invest (1990) 2.03
Isolation of filaments from brain. Science (1971) 2.03
Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest (1991) 2.01
Solid cancers after bone marrow transplantation. J Clin Oncol (2001) 1.99
Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: a possible mechanism of inflammatory demyelination. Proc Natl Acad Sci U S A (1978) 1.97
Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice. Nature (1984) 1.95
Senile plaques and cerebral amyloidosis in aged dogs. A histochemical and ultrastructural study. Lab Invest (1970) 1.93
GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination. Neuron (1996) 1.91
Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann Neurol (1995) 1.91
Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann Neurol (1991) 1.84
Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis. Lab Invest (1984) 1.83
The cytoskeleton of primary astrocytes in culture contains actin, glial fibrillary acidic protein, and the fibroblast-type filament protein, vimentin. J Neurochem (1981) 1.79
Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann Neurol (2001) 1.78
Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J Immunol (1995) 1.76
Progress in bilharziasis control. The situation in Egypt. WHO Chron (1967) 1.75
Isolation and characterization of glial filaments from human brain. J Cell Biol (1978) 1.74
Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors. Blood (2000) 1.74
An ultrastructural study of experimental demyelination and remyelination. I. Acute experimental allergic encephalomyelitis in the peripheral nervous system. Lab Invest (1969) 1.73
Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J Immunol (1991) 1.73
Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor. J Immunol (1990) 1.71
The epidemiology of Schistosoma haematobium and S. mansoni infections in the Egypt-49 project area. 4. Measurement of the incidence of bilharziasis. Bull World Health Organ (1966) 1.69
Colocalization of lymphocytes bearing gamma delta T-cell receptor and heat shock protein hsp65+ oligodendrocytes in multiple sclerosis. Proc Natl Acad Sci U S A (1991) 1.65
The lipid composition of purified bovine brain myelin. J Neurochem (1966) 1.62
Myelination in rat brain: changes in myelin composition during brain maturation. J Neurochem (1973) 1.59
Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol (1993) 1.58
On the presence of Ia-positive endothelial cells and astrocytes in multiple sclerosis lesions and its relevance to antigen presentation. J Neuroimmunol (1985) 1.56
Axons: isolation from mammalian central nervous system. Science (1972) 1.55
Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J Exp Med (1996) 1.53
On the development of CNS lesions in natural canine distemper encephalomyelitis. J Neurol Sci (1976) 1.53
Acute experimental allergic encephalomyelitis in the mouse: immunopathology of the developing lesion. Cell Immunol (1985) 1.52
Temperature-sensitive mutants of reovirus type 3: defects in viral maturation as studied by immunofluorescence and electron microscopy. Virology (1971) 1.50
Multiple sclerosis. Distribution of T cells, T cell subsets and Ia-positive macrophages in lesions of different ages. J Neuroimmunol (1983) 1.45
Chronic experimental allergic encephalomyelitis in inbred guinea pigs. An ultrastructural study. Lab Invest (1974) 1.44
Evidence of endogenous regulatory function of transforming growth factor-beta 1 in experimental allergic encephalomyelitis. Int Immunol (1992) 1.43
Hypothesis: a role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis. J Neuroimmunol (1988) 1.42
Ultrastructure of measles virus in cultures of hamster cerebellum. J Virol (1969) 1.42
Topical indomethacin and sunburn. Br J Dermatol (1974) 1.41
Invasion of neurones in vitro by non immune lymphocytes. An electron microscopic study. Br J Exp Pathol (1968) 1.41
Progressive demyelination and reparative phenomena in chronic experimental allergic encephalomyelitis. J Neuropathol Exp Neurol (1975) 1.40
Rapid degradation restricts measles virus matrix protein expression in a subacute sclerosing panencephalitis cell line. Proc Natl Acad Sci U S A (1986) 1.38
Reovirus type 3 encephalitis--a virologic and ultrastructural study. J Neuropathol Exp Neurol (1973) 1.36
Nervous tissue as an immune compartment: the dialect of the immune response in the CNS. Immunol Today (1994) 1.35
Isolation of myelin from nerve tissue. Methods Enzymol (1974) 1.35
Laparoscopic cholecystectomy as a "true" outpatient procedure: initial experience in 130 consecutive patients. J Gastrointest Surg (2000) 1.32
Mechanisms of immune injury in multiple sclerosis. Brain Pathol (1996) 1.30
Mucolipidosis IV. Clinical, ultrastructural, histochemical, and chemical studies of a case, including a brain biopsy. Arch Neurol (1976) 1.29
Experimental allergic encephalomyelitis. An electron microscopic study. Am J Pathol (1966) 1.28
Reactive nitrogen intermediates in human neuropathology: an overview. Dev Neurosci (1994) 1.27
Upregulation and coexpression of adhesion molecules correlate with relapsing autoimmune demyelination in the central nervous system. J Exp Med (1990) 1.27
The epidemiology of Schistosoma haematobium and S. mansoni infections in the Egypt-49 project area. 2. Prevalence of bilharziasis in relation to personal attributes and habits. Bull World Health Organ (1966) 1.26
Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy. II. General pathologic, neuropathologic, and biochemical aspects. Neurology (1977) 1.26
Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion. Lab Invest (1981) 1.25
Subacute sclerosing leukoencephalitis. II. Chemical studies including abnormal myelin and an abnormal ganglioside pattern. J Neuropathol Exp Neurol (1966) 1.24
Neuropathology of experimental allergic encephalomyelitis in inbred strains of mice. Lab Invest (1980) 1.24
Tropical spastic paraparesis: a model of virus-induced, cytotoxic T-cell-mediated demyelination? Ann Neurol (1989) 1.23
Large-scale application of Bayluscide and sodium pentachlorophenate in the Egypt-49 project area. Evaluation of relative efficacy and comparative costs. Bull World Health Organ (1966) 1.22
Cytochalasin B inhibits the maturation of measles virus. Virology (1983) 1.22
Quaking mouse: isolation and characterization of myelin protein. J Neurochem (1971) 1.22
An ultrastructural study of experimental demyelination and remyelination. 3. Chronic experimental allergic encephalomyelitis in the central nervous system. Lab Invest (1969) 1.20
Glial bridges and Schwann cell migration during chronic demyelination in the C.N.S. J Neurocytol (1978) 1.20
Control of macrophage Ia expression in neonatal mice--role of a splenic suppressor cell. J Immunol (1982) 1.20
Evidence of persistent blood-brain barrier abnormalities in chronic-progressive multiple sclerosis. Acta Neuropathol (1995) 1.20
Bulk preparation of CNS cytoskeleton and the separation of individual neurofilament proteins by gel filtration: dye-binding characteristics and amino acid compositions. J Neurochem (1982) 1.19
Taxol-induced neuropathy: short-term effects of local injection. J Neurocytol (1984) 1.19
Experimental autoimmune encephalomyelitis in mice lacking glial fibrillary acidic protein is characterized by a more severe clinical course and an infiltrative central nervous system lesion. Am J Pathol (1998) 1.19
Ultrastructural study of long-term measles infection in cultures of hamster dorsal-root ganglion. J Virol (1971) 1.18
On the association between microtubules and mitochondria within axons. Brain Res (1971) 1.18
Adoptively transferred chronic relapsing experimental autoimmune encephalomyelitis in the mouse. Neuropathologic analysis. Lab Invest (1984) 1.17
Osteosynthesis for a T-shaped fracture of the femoral neck and trochanter: a case report. J Orthop Surg (Hong Kong) (2008) 1.16
Vesicular disruption of myelin in autoimmune demyelination. J Neurol Sci (1975) 1.16
Electron microscopy and immunoperoxidase studies of early multiple sclerosis lesions. Neurology (1976) 1.16
On the occurrence of Schwann cells within the normal central nervous system. J Neurocytol (1976) 1.16
Immunopathology of multiple sclerosis: report on an international meeting held at the Institute of Neurology of the University of Vienna. J Neuroimmunol (1998) 1.14
Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies. Blood (1987) 1.14